Galsulfase biosimilar (GENERIUM Pharmaceuticals)

加硫酶生物类似药 (GENERIUM Pharmaceuticals)

Report date: 2024/11/20 17:17:24

Base Information

Drug NameGalsulfase biosimilar (GENERIUM Pharmaceuticals)

Drug Alias NameGEN-071GNR-071

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionGlycosaminoglycan degraders

TargetsGlycosaminoglycan

Therapy Area/IndicationsMucopolysaccharidosis VI

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesGenerium Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesGenerium Pharmaceuticals

Inactive CompaniesN/A

Active IndicationsMucopolysaccharidosis VI

Inactive IndicationsN/A

Other Information

ATC CodeN/A